miR-29b-1-5p is a prognostic biomarker in basal-like breast cancer that produces cytotoxic events through decreased levels of p-AKT and p-Nrf2 and inhibition of N-methyltransferase expression. The gene discussed is NFE2L2; the disease is breast carcinoma.